109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE "How to talk about Clinical Trails" (072822)

Dallas, TX US
July 28, 2022

Course summary

Available credit: 
  • 1.00 AMA
  • 1.00 Attendance
Course opens: 
07/28/2022
Course expires: 
07/28/2022
Event starts: 
07/28/2022 - 7:30am CDT
Event ends: 
07/28/2022 - 8:30am CDT
Cost:
$0.00
Part of: 
109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE 2022
Add to calendar: 
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390
United States
Course Director(s)

Amy Jones, M.D.

has no relevant financial relationships to disclose at this time.
Speaker(s)

David Eric Gerber, MD

has a financial relationship (Grant Or Contract) with Karyopharm;.
has a financial relationship (Grant Or Contract) with BerGenBio;.
has a financial relationship (Grant Or Contract) with AstraZeneca;.
has a financial relationship (Grant Or Contract) with Sagimet;.
has a financial relationship (Stock) with Gilead;.
has a financial relationship (Independent contractor) with Catalyst Therapeutics;.
has a financial relationship (Independent contractor) with Janssen;.
has a financial relationship (Independent contractor) with Sanofi;.
has a financial relationship (Independent contractor) with Regeneron;.

Erin Williams, MBA

has no relevant financial relationships to disclose at this time.

Available Credit

  • 1.00 AMA
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.